[化学抗原受体 (CAR) -T细胞的基本原理和药理机制]
1Department of Pharmacy, National Taiwan University Hospital; School of Pharmacy, National Taiwan University, Taiwan, ROC. enjoymyway@ntuh.gov.tw.
Hu li za zhi The journal of nursing
|November 24, 2025
概括
化学抗原受体T细胞 (CAR-T) 疗法通过基因修改患者的T细胞以向瘤,为某些血液癌症提供有效的治疗方法. 在这种先进的免疫疗法期间,护士对于监测副作用和确保患者安全至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 疗法是治疗不耐药或复发性血液恶性瘤的先进免疫疗法.
- 卡特-T疗法在治疗急性淋巴细胞白血病和扩散性大B细胞淋巴瘤等疾病方面表现出显著的疗效.
- 该疗法涉及基因工程患者的T细胞识别和消除癌细胞.
研究的目的:
- 提供关于CAR-T细胞疗法的全面概述.
- 要突出CAR-T治疗所需的多学科方法.
- 强调护理在管理CAR-T疗法及其相关毒性方面的关键作用.
主要方法:
- 患者评估和T细胞采集 (白血病).
- 用T细胞的基因工程来表达CAR,然后进行细胞扩张.
- 淋巴损伤化疗和CAR-T细胞输液.
主要成果:
- 卡尔-T细胞强烈扩张,分泌细胞因子,并诱导瘤细胞亡.
- 常见的不良反应包括细胞因子释放综合征和神经毒性,需要密切监测.
- 延迟的毒性,如泛cytopenia和低血糖球蛋白血症,需要长期的随访.
结论:
- 卡特-T疗法是对抗血液性恶性瘤的强大工具.
- 多学科合作和警的护理护理对于成功的CAR-T治疗至关重要.
- 有效管理不良事件和支持性护理是优化CAR-T治疗患者结果的关键.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.2K
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
12.4K
相关概念视频
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
Diversity of Antigen Receptors
1.4K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
